Tilden D - Search Results

1

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.

Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S. Secnik K, et al. Among authors: tilden d. Med Decis Making. 2005 Jan-Feb;25(1):56-70. doi: 10.1177/0272989X04273140. Med Decis Making. 2005. PMID: 15673582

2

A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.

Cottrell S, Tilden D, Robinson P, Bae J, Arellano J, Edgell E, Aristides M, Boye KS. Cottrell S, et al. Among authors: tilden d. Value Health. 2008 May-Jun;11(3):376-88. doi: 10.1111/j.1524-4733.2007.00256.x. Value Health. 2008. PMID: 18489664 Free article.

3

An economic assessment of quetiapine and haloperidol in patients with schizophrenia only partially responsive to conventional antipsychotics.

Tilden D, Aristides M, Meddis D, Burns T. Tilden D, et al. Clin Ther. 2002 Oct;24(10):1648-67. doi: 10.1016/s0149-2918(02)80069-8. Clin Ther. 2002. PMID: 12462294

4

Cost-utility analysis of the GC versus MVAC regimens for the treatment of locally advanced or metastatic bladder cancer.

Robinson P, Maase Hv, Bhalla S, Kielhorn A, Aristides M, Brown A, Tilden D. Robinson P, et al. Among authors: tilden d. Expert Rev Pharmacoecon Outcomes Res. 2004 Feb;4(1):27-38. doi: 10.1586/14737167.4.1.27. Expert Rev Pharmacoecon Outcomes Res. 2004. PMID: 19807333

5

A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.

Tilden DP, Mariz S, O'Bryan-Tear G, Bottomley J, Diamantopoulos A. Tilden DP, et al. Pharmacoeconomics. 2007;25(1):39-54. doi: 10.2165/00019053-200725010-00005. Pharmacoeconomics. 2007. PMID: 17192117

6

Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia.

Tilden D, Guarnieri C. Tilden D, et al. Value Health. 2016 Mar-Apr;19(2):145-52. doi: 10.1016/j.jval.2015.11.009. Epub 2015 Dec 29. Value Health. 2016. PMID: 27021747 Free article.

7

A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation.

Tilden DP, Chapman J, Davey PJ, Solly ML, Crowley S. Tilden DP, et al. Clin Transplant. 2004 Jun;18(3):312-20. doi: 10.1111/j.1399-0012.2004.00168.x. Clin Transplant. 2004. PMID: 15142054

8

Cost-analysis comparison of outpatient see-and-treat hysteroscopy service with other hysteroscopy service models.

Saridogan E, Tilden D, Sykes D, Davis N, Subramanian D. Saridogan E, et al. Among authors: tilden d. J Minim Invasive Gynecol. 2010 Jul-Aug;17(4):518-25. doi: 10.1016/j.jmig.2010.03.009. J Minim Invasive Gynecol. 2010. PMID: 20621013

9

Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective.

Arora N, Makino K, Tilden D, Lobotesis K, Mitchell P, Gillespie J. Arora N, et al. Among authors: tilden d. J Med Econ. 2018 Aug;21(8):799-809. doi: 10.1080/13696998.2018.1474746. Epub 2018 May 30. J Med Econ. 2018. PMID: 29741126 Free article.

10

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe.

Schiller J, Tilden D, Aristides M, Lees M, Kielhorn A, Maniadakis N, Bhalla S. Schiller J, et al. Among authors: tilden d. Lung Cancer. 2004 Jan;43(1):101-12. doi: 10.1016/j.lungcan.2003.06.003. Lung Cancer. 2004. PMID: 14698544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters